Evidence map›Paper›PMID 30232464›Full record

ArticleLeukemia2018

Correction: Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.

T Maekawa, Y Osawa, T Izumi, S Nagao, K Takano, Y Okada, N Tachi, M Teramoto, T Kawamura, T Horiuchi and 10 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

T MaekawaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan. dri3011@ndmc.ac.jp.
Y OsawaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T IzumiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
S NagaoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
K TakanoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Y OkadaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
N TachiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
M TeramotoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T KawamuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T HoriuchiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
R SagaDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
S KatoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
T YamamuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
J WatanabeDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
A KobayashiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
S KobayashiDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
K SatoDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
M HashimotoSuzu Project Laboratory, Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
S SuzuSuzu Project Laboratory, Center for AIDS Research, Kumamoto University, Kumamoto, Japan.
F KimuraDivision of Hematology, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to the insufficient specificity of the anti-myeloproliferative leukemia protein (MPL) antibody in the original version of this Article, Figure 6 and parts of Figures 2a, 4e, and 5a do not represent the correct information. The corrected version of Figure 6 is in this correction and those of Figures 2a, 4e, and 5a are shown in the supplemental information.

Identifiers

PMID30232464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.